Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 2 Interventional

A Study of STA-4783 in Combination With Weekly Paclitaxel for Treatment of Patients With Soft Tissue Sarcomas

ClinicalTrials.gov ID: NCT00087997

Public ClinicalTrials.gov record NCT00087997. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 2, 2026, 12:45 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

The purpose of this study is to evaluate the safety and effectiveness of an experimental study drug (STA-4783) combined with an approved cancer medicine, paclitaxel, in the treatment of soft tissue sarcomas. Paclitaxel (Taxol®) has been approved and used in the United States since 1992.

Study identification

NCT ID
NCT00087997
Recruitment status
Completed
Study type
Interventional
Phase
Phase 2
Lead sponsor
Synta Pharmaceuticals Corp.
Industry
Enrollment
80 participants

Conditions and interventions

Interventions

Drug

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Jul 2004 (Type not available)
Primary completion
Not listed
Completion
Oct 2005 (Type not available)
Last update posted
Jun 20, 2006

2004 – 2005

United States locations

U.S. sites
26
U.S. states
19
U.S. cities
25
Facility City State ZIP Site status
Arizona Cancer Center Scottsdale Arizona 85258 —
Arizona Cancer Center Tucson Arizona 85724 —
UCLA Los Angeles California 90095 —
Yale University School of Medicine New Haven Connecticut 06520 —
University of Florida Gainesville Florida 32610 —
H. Lee Moffitt Cancer Center Tampa Florida 33612 —
Palm Beach Cancer Institute West Palm Beach Florida 33401 —
Winship Cancer Institute Atlanta Georgia 30322 —
University of Chicago Department of Medicine Chicago Illinois 60637 —
Via Christi Regional Med. Center (Wichita CCOP) Wichita Kansas 67214 —
University of Louisville Hospital Louisville Kentucky 40202 —
Feist-Weiller Cancer Center Shreveport Louisiana 71103 —
Dana-Farber Cancer Institute Boston Massachusetts 02115 —
University of Michigan Ann Arbor Michigan 48109 —
Wayne State University Detroit Michigan 48201 —
Genesys Hurley Cancer Institute Flint Michigan 48503 —
Washington University School of Medicine St Louis Missouri 63110 —
University of Nebraska Medical Center Omaha Nebraska 68198 —
NYU Cancer Institute Clinical Center New York New York 10016 —
Herbert Irving Cancer Center New York New York 10032 —
Carolinas Medical Center/Blumenthal Cancer Center Charlotte North Carolina 28203 —
Oregon Health and Science University Portland Oregon 97239 —
Hillman Cancer Center Pittsburgh Pennsylvania 15232 —
The West Clinic Memphis Tennessee 38120 —
The Sarah Cannon Cancer Center Nashville Tennessee 37203 —
MD Anderson Cancer Center Houston Texas 77030 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 1 non-U.S. site.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00087997, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Jun 20, 2006 · Synced Oct 2, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT00087997 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →